Table 1.
Clinical data of patients with OSCC
| # (%) | Median age at diagnosis (range) | Observation time (range) | ||||
|---|---|---|---|---|---|---|
| Women |
17 (0.24) |
57 (48–76) years |
16 (3–27) months |
|||
| Men |
54 (0.76) |
58 (36–84) years |
14 (3–24) months |
|||
| Deceased |
10 (0.14) |
|
|
|
|
|
| Current status unknown |
14 (0.2) |
|
|
|
|
|
|
Tumour location |
# (%) |
|
|
|
|
|
| Hypopharinx |
5 (0.07) |
|
|
|
|
|
| Larynx |
2 (0.03) |
|
|
|
|
|
| Lips |
1 (0.01) |
|
|
|
|
|
| Mouth: |
36 (0.51) |
|
|
|
|
|
| Tongue |
14 (0.20) |
|
|
|
|
|
| Floor of the mouth |
13 (0.18) |
|
|
|
|
|
| Retromolar trigone |
3 (0.04) |
|
|
|
|
|
| Lower alveolus |
3 (0.04) |
|
|
|
|
|
| Buccal mucosa |
2 (0.03) |
|
|
|
|
|
| Upper alveolus |
1 (0.01) |
|
|
|
|
|
| Oropharynx |
27 (0.38) |
|
|
|
|
|
|
TNM classification |
|
|
|
|
|
|
|
Tumour |
# (%) |
Lymph node status |
# (%) |
Distant metastasis |
# (%) |
|
| Tis |
1 (0.01) |
N0 |
27 (0.38) |
M0 |
69 (0.97) |
|
| T1 |
5 (0.07) |
N1 or higher |
44 (0.62) |
M1 |
2 (0.03) |
|
| T2 |
20 (0.28) |
|
|
|
|
|
| T3 |
11 (0.25) |
|
|
|
|
|
| T4 |
34 (0.48) |
|
|
|
|
|
|
Disease stage |
# (%) |
|
Histologic grading |
|
# (%) |
|
| 0 |
1 (0.01) |
|
Carcinoma in situ |
|
2 (0.03) |
|
| I |
4 (0.06) |
|
Grade 1 |
|
12 (0.17) |
|
| II |
11 (0.15) |
|
Grade 2 |
|
45 (0.63) |
|
| III |
7 (0.10) |
|
Grade 3 |
|
12 (0.17) |
|
| IVA |
35 (0.49) |
|
|
|
|
|
| IVB |
11 (0.15) |
|
|
|
|
|
| IVC | 2 (0.03) | |||||